Results 51 to 60 of about 4,453 (214)

FORMULATION AND EVALUATION OF NANOSUSPENSION OF VALSARTAN

open access: yes, 2018
Objective: The objective of the present research work was to formulate and evaluate Valsartan nanosuspension by nanoprecipitation ultra sonication method using different polymers to enhance solubility and bioavailability of the poorly water-soluble drug ...
Shikha Agrawal   +5 more
core   +2 more sources

Dual‐Peptide Nanoplatform: Mesoporous Silica Nanoparticles Functionalized With a Cell‐Penetrating Peptide and Loaded With Rationally Designed Antimicrobial Peptides for Tuberculosis Therapy

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 21, 5 June 2026.
Machine learning–guided engineering of a plectasin‐derived peptide yields DC05, a potent antimycobacterial candidate. Encapsulation into tuftsin‐functionalized mesoporous silica nanoparticles enhances intracellular delivery, stability, and activity against Mycobacterium tuberculosis while maintaining low cytotoxicity and minimal hemolysis. The combined
Christian S. Carnero Canales   +12 more
wiley   +1 more source

Biochemical characterization of bioinspired nanosuspensions from Swertia chirayita extract and their therapeutic effects through nanotechnology approach.

open access: yesPLoS ONE
Swertia chirayita is used as a traditional medicinal plant due to its pharmacological activities, including antioxidant, antidiabetic, antimicrobial, and cytotoxic.
Ayesha Raza   +6 more
doaj   +1 more source

NANOSUSPENSIONS – A REVIEW

open access: yes, 2020
The interest in the preparation and application of nanometer-sized materials is increasing due to their tremendous potential as a drug delivery system with wide range of applications. Recently, nanoscale systems have received much interest as a way to resolve solubility issues because of their cost-effectiveness and technical simplicity compared to ...
openaire   +2 more sources

Tailored Porous Bimetallic Nanozyme Platform for Full‐Cycle Therapeutics of Intestinal Ischemia/Reperfusion

open access: yesAdvanced Science, Volume 13, Issue 34, 19 June 2026.
ABSTRACT Intestinal ischemia/reperfusion (I/R) injury presents a biphasic pathology: an acute oxidative‐inflammatory phase leading to organ failure, and a recovery phase marked by mucosal dysfunction and bacterial translocation. The developed MPB@TA‐Cu‐Ma nanocomposite functions as a dual‐phase therapeutic platform with significant efficacy. It rapidly
Chenghao Qiu   +15 more
wiley   +1 more source

Formulation And In Vivo Evaluation Of Ritonavir Nanosuspension

open access: yes, 2023
Aim: Formulation and in vivo evaluation of Ritonavir nanosuspension. Objectives: To study the significance variance in the pharmacokinetic parameters of  ritonavir.
P.Bhaskar Reddy   +2 more
core   +1 more source

Increasing Possibilities of Nanosuspension

open access: yesJournal of Nanotechnology, 2013
Nowadays, a very large proportion of new drug candidates emerging from drug discovery programmes are water insoluble and thus poorly bioavailable. To avoid this problem, nanotechnology for drug delivery has gained much interest as a way to improve the solubility problems. Nano refers to particles size range of 1–1000 nm. The reduction of drug particles
Kumar Bishwajit Sutradhar   +2 more
openaire   +3 more sources

Theranostic nanoplatform for high‐performance dual‐modal magnetic resonance imaging‐guided therapy of orthotopic hepatocellular carcinoma

open access: yesBMEMat, Volume 4, Issue 2, June 2026.
This article introduces a biomimetic Mn‐doped polydopamine nanoplatform (HAMM NPs) coated with cancer cell membranes. It enables targeted hepatocellular carcinoma theranostics via T1/T2 dual‐mode magnetic resonance imaging and tumor microenvironment‐triggered sonodynamic therapy/chemodynamic therapy, achieving potent antitumor efficacy in subcutaneous ...
Jiayin Lin   +7 more
wiley   +1 more source

Formulation and Evaluation of Teneligliptin Nanosuspension

open access: yes, 2021
In this present study, the drug Teneligliptin is selected based on literature review for the management of Type-2 Diabetes mellitus. ❖ The drug-excipient compatibility study results showed that there is no chemical change occur between the drug and the ...
Sreekala, M G
core  

Formulation and Evaluation of Lamivudine Nanosuspension

open access: yes, 2021
The present research aimed to develop & Evaluation of Lamivudine Nanosuspension. Lamivudine is a potent in vitro inhibitor of human immune deficiency virus belongs to the category of anti-retroviral drugs.
Hari Chandana, Guduru   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy